Moisés Garcı́a-Arencibia

8.3k total citations · 2 hit papers
36 papers, 6.4k citations indexed

About

Moisés Garcı́a-Arencibia is a scholar working on Pharmacology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Moisés Garcı́a-Arencibia has authored 36 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pharmacology, 17 papers in Cellular and Molecular Neuroscience and 9 papers in Neurology. Recurrent topics in Moisés Garcı́a-Arencibia's work include Cannabis and Cannabinoid Research (16 papers), Neuroscience and Neuropharmacology Research (10 papers) and Parkinson's Disease Mechanisms and Treatments (9 papers). Moisés Garcı́a-Arencibia is often cited by papers focused on Cannabis and Cannabinoid Research (16 papers), Neuroscience and Neuropharmacology Research (10 papers) and Parkinson's Disease Mechanisms and Treatments (9 papers). Moisés Garcı́a-Arencibia collaborates with scholars based in Spain, United Kingdom and United States. Moisés Garcı́a-Arencibia's co-authors include David C. Rubinsztein, Diego L. Medina, Pasqualina Colella, Andrea Ballabio, Carmine Settembre, Marco Sardiello, Serkan Erdin, Francesco Vetrini, Vinicia Assunta Polito and Chiara Di Malta and has published in prestigious journals such as Science, Cell and Physiological Reviews.

In The Last Decade

Moisés Garcı́a-Arencibia

36 papers receiving 6.3k citations

Hit Papers

TFEB Links Autophagy to Lysosomal Biogenesis 2010 2026 2015 2020 2011 2010 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. TFEB Links Autophagy to Lysosomal Biogenesis
    2011 2.5k citations Carmine Settembre, Chiara Di Malta et al. Science profile →
  2. Regulation of Mammalian Autophagy in Physiology and Pathophysiology
    2010 1.4k citations Sovan Sarkar, Moisés Garcı́a-Arencibia et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Moisés Garcı́a-Arencibia Spain 26 3.4k 2.4k 1.3k 1.1k 1.0k 36 6.4k
Shinji Saiki Japan 36 2.9k 0.8× 3.2k 1.3× 512 0.4× 1.1k 1.0× 1.2k 1.2× 139 7.2k
Asok Kumar United States 36 2.5k 0.8× 2.8k 1.2× 735 0.6× 1.6k 1.5× 3.7k 3.5× 73 7.5k
Konstantinos Palikaras Greece 27 3.2k 1.0× 3.9k 1.6× 437 0.3× 602 0.6× 1.8k 1.7× 56 7.5k
Panaiyur S. Mohan United States 31 1.7k 0.5× 1.9k 0.8× 501 0.4× 1.7k 1.6× 2.3k 2.2× 44 5.1k
Yong‐Keun Jung South Korea 48 2.2k 0.7× 5.5k 2.3× 529 0.4× 1.3k 1.2× 1.6k 1.5× 147 8.7k
Aviva M. Tolkovsky United Kingdom 43 1.8k 0.5× 4.3k 1.8× 307 0.2× 1.2k 1.1× 1.1k 1.0× 89 7.5k
Kira M. Holmström United States 24 2.6k 0.8× 4.8k 2.0× 275 0.2× 723 0.7× 1.4k 1.3× 28 7.8k
Marco Sardiello United States 31 4.5k 1.3× 3.9k 1.6× 350 0.3× 2.0k 1.9× 2.4k 2.3× 47 8.9k
Der‐Fen Suen Taiwan 14 3.1k 0.9× 4.1k 1.7× 213 0.2× 811 0.8× 999 1.0× 17 6.2k
Derek P. Narendra United States 21 7.4k 2.2× 8.1k 3.4× 500 0.4× 1.8k 1.6× 2.2k 2.1× 37 12.9k

Countries citing papers authored by Moisés Garcı́a-Arencibia

Since Specialization
Citations

This map shows the geographic impact of Moisés Garcı́a-Arencibia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moisés Garcı́a-Arencibia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moisés Garcı́a-Arencibia more than expected).

Fields of papers citing papers by Moisés Garcı́a-Arencibia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Moisés Garcı́a-Arencibia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moisés Garcı́a-Arencibia. The network helps show where Moisés Garcı́a-Arencibia may publish in the future.

Co-authorship network of co-authors of Moisés Garcı́a-Arencibia

This figure shows the co-authorship network connecting the top 25 collaborators of Moisés Garcı́a-Arencibia. A scholar is included among the top collaborators of Moisés Garcı́a-Arencibia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Moisés Garcı́a-Arencibia. Moisés Garcı́a-Arencibia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Agís-Torres, Ángel, Mónica Söllhuber, María Victoria Fernández, et al.. (2021). Analogues of cannabinoids as multitarget drugs in the treatment of Alzheimer's disease. European Journal of Pharmacology. 895. 173875–173875. 12 indexed citations
2.
García, Concepción, María Gómez‐Cañas, Belén Palomares, et al.. (2018). Benefits of VCE-003.2, a cannabigerol quinone derivative, against inflammation-driven neuronal deterioration in experimental Parkinson’s disease: possible involvement of different binding sites at the PPARγ receptor. Journal of Neuroinflammation. 15(1). 19–19. 55 indexed citations
3.
Gómez‐Cañas, María, Paula Morales, Carmen Navarrete, et al.. (2016). Biological characterization of PM226, a chromenoisoxazole, as a selective CB2 receptor agonist with neuroprotective profile. Pharmacological Research. 110. 205–215. 26 indexed citations
4.
Deiana, Valeria, María Gómez‐Cañas, M. Ruth Pazos, et al.. (2016). Tricyclic pyrazoles. Part 8. Synthesis, biological evaluation and modelling of tricyclic pyrazole carboxamides as potential CB2 receptor ligands with antagonist/inverse agonist properties. European Journal of Medicinal Chemistry. 112. 66–80. 18 indexed citations
5.
Gómez‐Cañas, María, Paula Morales, Dow P. Hurst, et al.. (2015). Synthesis, pharmacological evaluation and docking studies of pyrrole structure-based CB 2 receptor antagonists. European Journal of Medicinal Chemistry. 101. 651–667. 14 indexed citations
6.
Menzies, Fiona M., Moisés Garcı́a-Arencibia, Sara Imarisio, et al.. (2014). Calpain inhibition mediates autophagy-dependent protection against polyglutamine toxicity. Cell Death and Differentiation. 22(3). 433–444. 88 indexed citations
7.
Sánchez-Reus, Marı́a Isabel, Irene Iglesias Peinado, Miguel A. Pozo, et al.. (2013). Neuroprotective Properties of Standardized Extracts of Hypericum perforatum on Rotenone Model of Parkinson’s Disease. CNS & Neurological Disorders - Drug Targets. 12(5). 665–679. 41 indexed citations
8.
Pérez-Macías, Natalia, Nuria E. Campillo, Concepción Pérez, et al.. (2013). Cannabinoid agonists showing BuChE inhibition as potential therapeutic agents for Alzheimer's disease. European Journal of Medicinal Chemistry. 73. 56–72. 43 indexed citations
9.
Settembre, Carmine, Chiara Di Malta, Vinicia Assunta Polito, et al.. (2011). TFEB Links Autophagy to Lysosomal Biogenesis. Science. 332(6036). 1429–1433. 2496 indexed citations breakdown →
10.
Calle, Consuelo, Patricio Aller, & Moisés Garcı́a-Arencibia. (2011). Identification of virtual signal transducers and activators of transcription response elements in the human insulin receptor gene promoter. Computational Biology and Chemistry. 35(6). 333–335. 1 indexed citations
11.
Sarkar, Sovan, Viktor I. Korolchuk, Maurizio Renna, et al.. (2011). Complex Inhibitory Effects of Nitric Oxide on Autophagy. Molecular Cell. 43(1). 19–32. 326 indexed citations
12.
Garcı́a-Arencibia, Moisés, et al.. (2010). Autophagy, a guardian against neurodegeneration. Seminars in Cell and Developmental Biology. 21(7). 691–698. 141 indexed citations
13.
Underwood, Benjamin R., Sara Imarisio, Angeleen Fleming, et al.. (2010). Antioxidants can inhibit basal autophagy and enhance neurodegeneration in models of polyglutamine disease. Human Molecular Genetics. 19(17). 3413–3429. 134 indexed citations
14.
Metcalf, Daniel, Moisés Garcı́a-Arencibia, Warren E. Hochfeld, & David C. Rubinsztein. (2010). Autophagy and misfolded proteins in neurodegeneration. Experimental Neurology. 238(1). 22–28. 112 indexed citations
15.
Holmberg, M., Eva Teuling, Moisés Garcı́a-Arencibia, et al.. (2010). A30 Identification of MOAG-4/SERF as a regulator of age related proteotoxicity. Journal of Neurology Neurosurgery & Psychiatry. 81(Suppl 1). A10.1–A10. 1 indexed citations
16.
17.
Sagredo, Onintza, et al.. (2007). Cannabinoids and Neuroprotection in Basal Ganglia Disorders. Molecular Neurobiology. 36(1). 82–91. 74 indexed citations
18.
González, Sara, Camila Scorticati, Moisés Garcı́a-Arencibia, et al.. (2006). Effects of rimonabant, a selective cannabinoid CB1 receptor antagonist, in a rat model of Parkinson's disease. Brain Research. 1073-1074. 209–219. 89 indexed citations
19.
Garcı́a-Arencibia, Moisés, et al.. (2004). 17β-Estradiol transcriptionally represses human insulin receptor gene expression causing cellular insulin resistance. Leukemia Research. 29(1). 79–87. 18 indexed citations
20.
Calle, Consuelo, Javier Campión, Moisés Garcı́a-Arencibia, Begoña Maestro, & Norma Dávila. (2003). Transcriptional inhibition of the human insulin receptor gene by aldosterone. The Journal of Steroid Biochemistry and Molecular Biology. 84(5). 543–553. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shinji Saiki Breakdown of academic impact, for papers by Asok Kumar Breakdown of academic impact, for papers by Konstantinos Palikaras Breakdown of academic impact, for papers by Panaiyur S. Mohan Breakdown of academic impact, for papers by Yong‐Keun Jung Breakdown of academic impact, for papers by Aviva M. Tolkovsky Breakdown of academic impact, for papers by Kira M. Holmström Breakdown of academic impact, for papers by Marco Sardiello Breakdown of academic impact, for papers by Der‐Fen Suen Breakdown of academic impact, for papers by Derek P. Narendra
Rankless by CCL
2026